Related references
Note: Only part of the references are listed.Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus:: Data from LUMINA, a multiethnic US cohort (LUMINA L)
Graciela S. Alarcon et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Time to renal disease and end-stage renal disease in PROFILE:: A multiethnic lupus cohort
Graciela S. Alarcon et al.
PLOS MEDICINE (2006)
Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis
Cecilia P. Chung et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Captopril effect on prostaglandin E2, thromboxane B2 and proteinuria in lupus nephritis patients
L Daza et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2005)
Cardiovascular disease in lupus patients: Should all patients be treated with statins and aspirin?
IN Bruce
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2005)
Angiotensin inhibition or blockade for the treatment of patients with quiescent lupus nephritis and persistent proteinuria
KC Tse et al.
LUPUS (2005)
An ACE inhibitor reduces Th2 cytokines and TGF-β1 and TGF-β2 isoforms in murine lupus nephritis
DA De Albuquerque et al.
KIDNEY INTERNATIONAL (2004)
Preventing microalbuminuria in type 2 diabetes
P Ruggenenti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The American college of rheumatology response criteria for systemic lupus erythematosus clinical trials - Measures of overall disease activity
MH Liang
ARTHRITIS AND RHEUMATISM (2004)
Captopril prevents experimental autoimmune myocarditis
LM Godsel et al.
JOURNAL OF IMMUNOLOGY (2003)
Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies -: Do the benefits outweigh the risks?: A decision analysis
DG Wahl et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Should low-dose aspirin also be a background therapy for all patients with systemic lupus erythematosus (SLE)?
AN Malaviya et al.
LUPUS (2000)
Share Paper
